Wednesday, November 26, 2014 11:38:59 AM
Narcotic Control Regulations (NCR) apply.
The NCR define "advertisement" as any representation by any means
whatever for the purpose of promoting directly or indirectly the sale
or disposal of a narcotic.
Section 70 of the NCR states that:
70. No person shall
(a) publish or cause to be published or furnish any advertisement
respecting a narcotic unless the symbol “N” is clearly and
conspicuously displayed in the upper left-hand quarter thereof or, if
the advertisement consists of more than one page, on the first page
thereof;
(b) publish or cause to be published or furnish any advertisement to
the general public respecting a narcotic; or
(c) advertise in a pharmacy a preparation referred to in section 36.
Licensed producers must also respect section 9 of the Food and Drugs
Act (FDA) with respect to advertising.
Section 9 prohibits the advertising of any drug in a manner that is
false, misleading or deceptive or likely to create an erroneous
impression regarding its character, value, quantity, composition,
merit or safety.
Section 72 of the Marihuana for Medical Purposes Regulations also
prohibit any reference to the Controlled Drugs and Substances Act, the
Food and Drugs Act or any regulations made under those Acts on a
labels or advertisement for dried marihuana, unless the reference is
something specifically required under these Acts or their regulations.
Section 72 states that: It is prohibited to include a reference,
direct or indirect, to the Act, the Food and Drugs Act or any
regulations made under those Acts on a label of or in an advertisement
for dried marihuana unless the reference is a specific requirement of
either of those Acts or those regulations.
You will note that the provisions above do not specify what is
allowed, but discuss what is prohibited. Flexibility is given to the
licensed producer to work within these requirements.
If you have any additional questions, please do not hesitate to send
us your questions by email at MMPR-RMFM@hc-sc.gc.ca or call us at
1-866-337-7705.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM